tacs mtt reagent (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
93
Structured Review
R&D Systems
tacs mtt reagent
Tacs Mtt Reagent, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 59 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tacs+mtt+reagent/MTT+Reagent/pmc12521541-118-5-8
Average 93 stars, based on 59 article reviews
Tacs Mtt Reagent, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 59 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tacs+mtt+reagent/MTT+Reagent/pmc12521541-118-5-8
Average 93 stars, based on 59 article reviews
tacs mtt reagent - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
MTT Assay:Article Title: XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression. Article Snippet: .. At 48 h after treatment, 10 μl Article Title: DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization Article Snippet: .. Post-treatment, 10 μl of Article Title: DCLK1-isoform2 alternative splice variant promotes pancreatic tumor immunosuppressive M2-macrophage polarization Article Snippet: .. Cell proliferation assays Post-treatment, 10 μl of Article Title: A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growth. Article Snippet: .. Afterward, we treated cells with Article Title: DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4 Article Snippet: .. Post-treatment, 10 μL Article Title: XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression Article Snippet: .. At 48 h after treatment, 10 μl Article Title: DCLK1-isoform2 alternative splice variant promotes pancreatic tumor immunosuppressive M2-macrophage polarization Article Snippet: .. Post-treatment, 10 μl of Article Title: A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growth Article Snippet: .. Afterward, we treated cells with Incubation:Article Title: XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression. Article Snippet: .. At 48 h after treatment, 10 μl Article Title: DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization Article Snippet: .. Post-treatment, 10 μl of Article Title: DCLK1-isoform2 alternative splice variant promotes pancreatic tumor immunosuppressive M2-macrophage polarization Article Snippet: .. Cell proliferation assays Post-treatment, 10 μl of Article Title: DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4 Article Snippet: .. Post-treatment, 10 μL Article Title: XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression Article Snippet: .. At 48 h after treatment, 10 μl Article Title: DCLK1-isoform2 alternative splice variant promotes pancreatic tumor immunosuppressive M2-macrophage polarization Article Snippet: .. Post-treatment, 10 μl of |
![MINK1 localizes to cell-cell junctions and its overexpression enhances cell adhesion. A, mRNA expression of MINK1, CTNNB1, and AXIN2 measured by qRT-PCR 48 and 72 hours after siRNA transfection. Indicated are mean expression levels relative to ACTB expression with SD from four independent transfections. Significance determined by one-way ANOVA followed by Dunnett multiple comparison test (*, P < 0.05; **, P < 0.01; ***, P < 0.001). Note, the same HeLa AXIN2 mRNA quantification data are also shown in Supplementary Fig. S4D. B, MINK1 protein levels in HeLa cells after treatment with neddylation inhibitor MLN4924 [3 mmol/L] as measured by WB. Shown are relative mean signals normalized to DMSO-treated samples with SD from three independent experiments. Significance determined by one-way ANOVA, **, P < 0.01. C, Live imaging of HeLa SEC-C cells expressing endogenously mNeonGreen-tagged MINK1. Scale bars, 10 μm. D, Adhesion assay with U2OS cells overexpressing MINK1-GFPand GFP, respectively. Adhesion to collagen matrix after 1 hour was quantified by staining of firmly attached cells with Crystal Violet. Indicated is mean absorbance with SD of independent experiments with two different GFP/MINK1-GFP clones and eight technical replicates/condition. Significance determined by two-way ANOVA followed by Sidak multiple comparison test (***, P < 0.0003). E, <t>MTT</t> <t>proliferation</t> assay in Colo320 cells treated with siRNA against β-catenin or MINK1. Shown is the mean absorbance from triplicate measurements. Significance relative to control determined by one-way ANOVA followed by Dunnett multiple comparison test (*, P < 0.05; **, P < 0.01). n.s., not significant.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_2431/pmc07302431/pmc07302431__nihms-1595998-f0006.jpg)